Dietary approach to stop hypertension (DASH) diet in migraine
Not Applicable
- Conditions
- Migraine.Migraine without auraG43.0
- Registration Number
- IRCT20121216011763N38
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Patients who agree to participate in the study
Diagnosis of migraine by a neurologist according to ICHD-3
Aged between 20 to 50 years old
Body mass index between 18.5-30 kg/m2
Exclusion Criteria
Men with migraine
Migraine with aura
Diagnosis of other disease such as cardiovascular disease, hypertension, diabetes, liver disease, kidney disease, thyroid disorders, malignancies and other neurological problem
Pregnancy and lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Migraine severity. Timepoint: At baseline and after 12 weeks. Method of measurement: Visual analogue scale.;Migraine frequency. Timepoint: At baseline and after 12 weeks. Method of measurement: Clinical examination.;Migraine duration. Timepoint: At baseline and after 12 weeks. Method of measurement: Clinical examination.;Headache impact test. Timepoint: At baseline and after 12 weeks. Method of measurement: HIT questionnaire.;Serum Nitric Oxide. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Serum vitamin C. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Total antioxidant capacity. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Total oxidant capacity. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Serum glutathion. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: At baseline and after 12 weeks. Method of measurement: Sphygmomonometer.;Weight. Timepoint: At baseline and after 12 weeks. Method of measurement: Digital scale.